StonvexLoading…
StonvexStonvexStonvexCore line items from CPRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $588.99M | $491.73M | $398.20M | $214.20M |
Operating Income | $257.78M | $195.12M | $86.81M | $101.84M |
Net Income | $214.33M | $163.89M | $71.41M | $83.08M |
EPS (Diluted) | $1.68 | $1.31 | $0.63 | $0.75 |
Total Assets | $1.10B | $851.41M | $470.11M | $375.63M |
Total Liabilities | $149.71M | $123.78M | $82.23M | $75.21M |
Cash & Equivalents | $709.17M | $517.55M | $137.64M | $298.39M |
Free Cash Flow OCF − CapEx | $208.61M | $239.25M | $143.37M | $116.02M |
Shares Outstanding | 122.51M | 120.88M | 107.12M | 105.26M |